A better understanding of the possible role of GLP-2 in influencing food intake through the gut–brain axis could provide insights into the development of new therapeutic approaches in the treatment of some pathological conditions, such as obesity. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.